STANDARD INDUSTRIAL CLASSIFICATION 2834
Pharmaceutical Preparations
Documented enforcement actions, accounting mechanics, and penalty records for companies operating under SIC code 2834.
SECTOR ENFORCEMENT BENCHMARKS
- 4 major corporate fraud cases are documented under SIC 2834: Pharmaceutical Preparations.
- Cumulative financial overstatements in this industry sector reach $10.3B.
- Total regulatory and criminal civil sanctions and penalties amount to $552.0M.
ENFORCEMENT CASES 4 SIC code 2834
TOTAL OVERSTATEMENT $10.3B Reported distortion
TOTAL PENALTIES $552.0M Sanctions & recoveries
JURISDICTIONS 4 Regulatory venues
ENFORCEMENT RECORDS (SIC 2834)
4 ACTIONS| Case Title | Company / Issuer | Jurisdiction | Status | Overstatement | Penalties |
|---|---|---|---|---|---|
| Bristol-Myers Squibb: $2B Channel Stuffing with Wholesaler Incentives | Bristol-Myers Squibb Company | US | Settled, neither admitted nor denied | $2.0B | $150.0M |
| Samsung BioLogics: 4.5 Trillion Won Acquisition Accounting Inflation | Samsung BioLogics Co., Ltd. | KR | Adjudicated | $3.8B | $7.0M |
| Valeant Pharmaceuticals: Undisclosed Captive Pharmacy Philidor and Channel Stuffing | Valeant Pharmaceuticals International, Inc. | CA | Settled, neither admitted nor denied | $58.0M | $45.0M |
| Kangmei Pharmaceutical: 30 Billion Yuan ($4.4B) Fabricated Cash Balances | Kangmei Pharmaceutical Co., Ltd. | CN | Adjudicated | $4.4B | $350.0M |